Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #28,851 to #28,900.
- Epitumomab cituxetan (2 revisions)
- Epizootic (2 revisions)
- Epoxide hydrolase 3 (2 revisions)
- Epratuzumab (2 revisions)
- Eprozinol (2 revisions)
- Epstein's syndrome (2 revisions)
- Eptifibatide (patient information) (2 revisions)
- Equagesic (2 revisions)
- Leptospirosis other diagnostic studies (2 revisions)
- Lerisetron (2 revisions)
- Lesch-Nyhan syndrome MRI (2 revisions)
- Lesch-Nyhan syndrome causes (2 revisions)
- Lesch-Nyhan syndrome classification (2 revisions)
- Lesch-Nyhan syndrome cost-effectiveness of therapy (2 revisions)
- Lesch-Nyhan syndrome electrocardiogram (2 revisions)
- Lesch-Nyhan syndrome future or investigational therapies (2 revisions)
- Lesch-Nyhan syndrome primary prevention (2 revisions)
- Lesch-Nyhan syndrome risk factors (2 revisions)
- Lesch-Nyhan syndrome secondary prevention (2 revisions)
- Lesch-Nyhan syndrome surgery (2 revisions)
- Lesch-Nyhan syndrome ultrasound (2 revisions)
- Letosteine (2 revisions)
- Leucine-rich repeats and iq motif containing 1 (2 revisions)
- Leucine rich repeat containing 15 (2 revisions)
- Leucine rich repeat containing 61 (2 revisions)
- Leucyl/cystinyl aminopeptidase (2 revisions)
- Leukemia echocardiography (2 revisions)
- Leukemia inhibitory factor receptor (2 revisions)
- Leukemia laboratory tests (2 revisions)
- Leukemia natural history (2 revisions)
- Leukocytosis (patient information) (2 revisions)
- Leukocytosis case study one (2 revisions)
- Leukocytosis cost-effectiveness of therapy (2 revisions)
- Leukocytosis epidemiology and demographics (2 revisions)
- Leukocytosis future or investigational therapies (2 revisions)
- Leukocytosis history and symptoms (2 revisions)
- Leukocytosis laboratory findings (2 revisions)
- Leukocytosis medical therapy (2 revisions)
- Leukocytosis natural history, complications and prognosis (2 revisions)
- Leukocytosis other diagnostic studies (2 revisions)
- Leukocytosis physical examination (2 revisions)
- Leukocytosis primary prevention (2 revisions)
- Leukocytosis risk factors (2 revisions)
- Leukocytosis screening (2 revisions)
- Leukocytosis secondary prevention (2 revisions)
- Leukotriene B4 (2 revisions)
- Leukotriene antagonist (2 revisions)
- Leuprolide (patient information) (2 revisions)
- Levallorphan (2 revisions)
- Levamisole (2 revisions)